A challenge confronting the Food and Drug Administration — and other regulators around the world — is how to regulate generative AI. The approach it uses for new drugs and devices isn’t appropriate. Instead, the FDA should be conceiving of LLMs as novel forms of intelligence. It should employ similar approaches to those it applies to clinicians.
A challenge confronting the Food and Drug Administration — and other regulators around the world — is how to regulate generative AI. The approach it uses for new drugs and devices isn’t appropriate. Instead, the FDA should be conceiving of LLMs as novel forms of intelligence. It should employ similar approaches to those it applies to clinicians.Generative AI has arrived in medicine. Normally, when a new device or drug enters the U.S.
Unfortunately, the usual approach to protecting the public and helping doctors and hospitals manage new health care technologies won’t work for generative AI. To realize the full clinical benefits of this technology while minimizing its risks, we will need a regulatory approach as innovative as generative AI itself., MD, is a professor of practice of public health and health policy at the Harvard T.H. Chan School of Public Health.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How to Regulate Generative AI in HealthcareA challenge confronting the Food and Drug Administration — and other regulators around the world — is how to regulate generative AI. The approach it uses for new drugs and devices isn’t appropriate. Instead, the FDA should be conceiving of LLMs as novel forms of intelligence. It should employ similar approaches to those it applies to clinicians.
Read more »
Can generative AI fix the NHS and boost the nation's health?Generative AI will be transformative for NHS patient outcomes, a senior government advisor says.
Read more »
Using Generative AI To Perform Life Reviews At Any Stage Of LifeDr. Lance B. Eliot is a world-renowned expert on Artificial Intelligence (AI) with over 7.8+ million amassed views of his AI columns and been featured on CBS 60 Minutes. As a CIO/CTO seasoned executive and high-tech entrepreneur, he combines practical industry experience with deep academic research.
Read more »
Overcoming Procrastination Via Generative AIDr. Lance B. Eliot is a world-renowned expert on Artificial Intelligence (AI) with over 7.8+ million amassed views of his AI columns and been featured on CBS 60 Minutes. As a CIO/CTO seasoned executive and high-tech entrepreneur, he combines practical industry experience with deep academic research.
Read more »
UC Health, APS working together to address health workforce shortageWanya Reese joined the Denver 7 team as a Weekend Morning Anchor and Reporter in July of 2023.
Read more »
Judge rejects claims that generative AI tanked political conspiracy case against Fugees rapper PrasWASHINGTON (AP) — A judge rejected a push for a new trial in a multimillion-dollar political conspiracy case against rapper Prakazrel “Pras” Michel of the
Read more »